These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Etretinate may work where acitretin fails. Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918 [TBL] [Abstract][Full Text] [Related]
7. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use. Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421 [TBL] [Abstract][Full Text] [Related]
10. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis. Pang ML; Murase JE; Koo J Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):953-64. PubMed ID: 18624682 [TBL] [Abstract][Full Text] [Related]
11. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. Starling J; Koo J J Drugs Dermatol; 2005; 4(6):690-6. PubMed ID: 16302554 [TBL] [Abstract][Full Text] [Related]
12. Treatment of nephrogenic systemic fibrosis with Re-PUVA. Duffy KL; Green L; Harris R; Powell D J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S39-40. PubMed ID: 18625379 [No Abstract] [Full Text] [Related]
13. Acitretin prescribing patterns in women of childbearing potential. Davis SA; Yentzer BA; Feldman SR J Drugs Dermatol; 2013 Jul; 12(7):799-802. PubMed ID: 23884494 [TBL] [Abstract][Full Text] [Related]
14. Acitretin in psoriasis: an overview of adverse effects. Katz HI; Waalen J; Leach EE J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S7-S12. PubMed ID: 10459140 [TBL] [Abstract][Full Text] [Related]
15. [Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy]. Almond-Roesler B; Orfanos CE Hautarzt; 1996 Mar; 47(3):173-7. PubMed ID: 8647698 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of acitretin in severe psoriasis. Geiger JM Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231 [TBL] [Abstract][Full Text] [Related]
17. [Acitretine]. Berbis P Ann Dermatol Venereol; 2001; 128(6-7):737-45. PubMed ID: 11460037 [TBL] [Abstract][Full Text] [Related]
18. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Ormerod AD; Campalani E; Goodfield MJ; Br J Dermatol; 2010 May; 162(5):952-63. PubMed ID: 20423353 [No Abstract] [Full Text] [Related]
19. Acitretin: no pregnancy during treatment and, as a precaution, for 3 years after discontinuation. Prescrire Int; 2013 Sep; 22(141):213. PubMed ID: 24171216 [No Abstract] [Full Text] [Related]
20. Biopharmaceutics of beta-cyclodextrin derivative-based formulations of acitretin in Sprague-Dawley rats. Liu X; Lin HS; Chan SY; Ho PC J Pharm Sci; 2004 Apr; 93(4):805-15. PubMed ID: 14999719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]